lecanemab | The Epoch Times

Many Ineligible for New Alzheimer’s Drugs: Study

A new class of Alzheimer's drugs offers hope of slowing cognitive decline. However, emerging research shows that only a fraction of patients may qualify for these potentially life-changing treatments due ...

August 28, 2023BY George Citroner

New Case Report Links 1 Death to New FDA-Approved Alzheimer’s Drug

A participant died in a clinical trial of a U.S. Food and Drug Administration (FDA)-approved antibody treatment for ...

June 13, 2023BY George Citroner

Alzheimer’s Drug Leqembi Gains FDA Panel’s Support for Full Approval

A group of independent advisers to the U.S. Food and Drug Administration (FDA) have voted to support regulatory ...

June 10, 2023BY Mimi Nguyen Ly

Lecanemab May Reverse Alzheimer’s Disease, But 3 Deaths Raise Questions

The U.S. Food and Drug Administration (FDA) granted Leqembi accelerated approval on Jan. 6, 2023. It is the seventh ...

January 8, 2023BY Stephanie Zhang, Ph.D.

FDA Grants Accelerated Approval for Alzheimer’s Drug Lecanemab

The U.S. Food and Drug Administration (FDA) on Friday granted accelerated approval for the experimental dementia drug lecanemab. ...

January 6, 2023BY Caden Pearson